C5-Modified nucleosides exhibiting anticancer activity

Bioorganic and Medicinal Chemistry Letters

Volumn 19, Issue 16, 2009, Pages 4688-4691

  Lee, Yoon Suk ^a   Park, Sun Min ^a   Kim, Hwan Mook ^b   Park, Song Kyu ^b   Lee, Kiho ^b   Lee, Chang Woo ^b   Kim, Byeang Hyean ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Anticancer; Cycloaddition; Isoxazole; Nucleoside; Triazole

Indexed keywords

5 ETHYNYLDEOXYURIDINE; ANTINEOPLASTIC AGENT; AZIDE; BENZYL BROMIDE; DEOXYURIDINE DERIVATIVE; IDOXURIDINE; IDOXURIDINE DERIVATIVE; ISOXAZOLE DERIVATIVE; NITRILE OXIDE; OXIME DERIVATIVE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYCLOADDITION; DRUG CYTOTOXICITY; DRUG SYNTHESIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DEOXYURIDINE; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; ISOXAZOLES; NUCLEOSIDES;

EID: 67749119952     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.06.072     Document Type: Article

References (24)

1. For statistical information about cancer, see: World Health Organisation http://www.who.int/mediacentre/factsheets/fs297/en/.
2. Cancer Research UK http://info.cancerresearchuk.org/cancerstats/incidence/age/.
3. Duelli D., and Lazebnik Y. Nat. Rev. Cancer 7 (2007) 968
4. Lauria F., Benfenati D., Raspadori D., Rondelli D., Zinzani P.L., and Tura S. Leuk. Lymphoma 11 (1993) 399
5. Pui C.H., Jeha S., and Kirkpatrick P. Nat. Rev. Drug Disc. 4 (2005) 369
6. Bonate P.L., Arthaud L., Cantrell W.R., Stephenson K., Secrist J.A., and Weitman S. Nat. Rev. Drug Disc. 5 (2006) 855
7. Issa J.-P., Kantarjian H., and Kirkpatrick P. Nat. Rev. Drug Disc. 4 (2005) 275
8. Gore S.D., Jones C., and Kirkpatrick P. Nat. Rev. Drug Disc. 5 (2006) 891
9. Meneni S., Ott I., Sergeant C.D., Sniady A., Gust R., and Dembinski R. Bioorg. Med. Chem. 15 (2007) 3082
10. Lee Y.S., Park S.M., and Kim B.H. Bioorg. Med. Chem. Lett. 19 (2009) 1126
11. Park S.M., Lee Y.S., and Kim B.H. Chem. Commun. (2003) 2912
12. Kolb H.C., Finn M.G., and Sharpless K.B. Angew. Chem., Int. Ed. 40 (2001) 2004
13. Rostovtsev V.V., Green L.G., Fokin V.V., and Sharpless K.B. Angew. Chem., Int. Ed. 41 (2002) 2596
14. Gramlich P.M.E., Wirges C.T., Gierlich J., and Carell T. Org. Lett. 10 (2008) 249
15. Kuo S.C., Lee H.Z., Juang J.P., Lin Y.T., Wu T.S., Chang J.J., Lednicer D., Paull K.D., Lin C.M., Hamel E., and Lee K.H. J. Med. Chem. 36 (1993) 1146
16. Lee H.-S., Lee J.H., Won H., Park S.-K., Kim H.M., Shin H.J., Park H.S., Sim C.J., and Kim H.-K. Lipids 44 (2009) 71
17. Lee Y.-S., and Kim B.H. Bioorg. Med. Chem. Lett. 12 (2002) 1395
18. Kim S.J., Lee J.Y., and Kim B.H. Bioorg. Med. Chem. Lett. 8 (1998) 1313
19. Kong J.R., Kim S.K., Moon B.J., Kim S.J., and Kim B.H. Nucleosides, Nucleotides, Nucleic Acids 20 (2001) 1751
20. McGuigan C., Yarnold C.J., Jones G., Velazquez S., Barucki H., Brancale A., Andrei G., Snoeck R., De Clercq E., and Balzarini J. J. Med. Chem. 34 (1991) 2275
21. Cristofoli W.A., Wiebe L.I., De Clercq E., Andrei G., Snoeck R., Balzarini J., and Knaus E.E. J. Med. Chem. 50 (2007) 2851
22. Terrence P.F., Spencer J.W., Bobst A.M., Descamps J., and De Clercq E. J. Med. Chem. 21 (1978) 228
23. Robins M.J., Manfredini S., Wood S.G., Wanklin R.J., Rennie B.A., and Sacks S.L. J. Med. Chem. 34 (1991) 2275
24. 3OD) δ 8.59 (s, 1H), 8.28 (s, 1H), 7.33 (br, 5H), 6.31 (t, J = 6.61 Hz, 1H), 5.59 (s, 2H), 4.41 (br, 1H), 3.94 (br, 1H), 3.84-3.71 (m, 2H), 2.31-2.20 (m, 2H); MS (EI+) m/z found 385.138, calcd 385.139.